Connect with us

Business

Pay Someone Else to Roll Your Joint, You Bet! – Cannabis Pre-Roll Sales Grow Faster Than Any Other Cannabis Product Catagories

Published

on

Why have to mess with a grinder, rolling papers, and time when you can buy a joint already rolled?

Custom Cones USA has joined forces with Headset, a cannabis data company, to release a white paper investigating the popularity of products among their customers. Titled “The State of the Pre-Roll Industry,” this comprehensive report delves into various aspects of pre-rolls, including sales growth, customer interest across generations, creation methods, packaging, and more.

Harrison Bard, the CEO and co-founder of Custom Cones USA, expressed, “This white paper showcases the ongoing expansion of the pre-roll industry and its potential to become the largest product category within the cannabis industry. We extend our gratitude to our partners at Headset for their collaboration on this white paper, offering reliable information to assist individuals in making well-informed business decisions within our ever-changing marketplace.”

Details of the Report

The report gathered data from diverse sources, including over 300 participants: recreational cannabis producers, hemp producers, medical cannabis producers, plant processors, vertically integrated brands, multi-state operators, dispensaries and cannabis brand agencies.

The white paper highlights the changing popularity of various product types by comparing year-over-year category sales growth in the United States and Canada from November 2021 to 2022. According to the paper, pre-rolls, edibles, drinks, vapes, and oil experienced an increase in market share, while tinctures, capsules, and topicals saw a decline.

The key insight derived from this data is that recreational categories like flower, pre-rolls, and vapes drive market growth, while wellness categories such as tinctures, capsules, and topicals are experiencing a decrease in market share.

The white paper reveals significant increases in Canada in terms of year-over-year segment growth. Infused pre-rolls saw a remarkable surge of 1,426%, hybrid strain pre-rolls experienced a growth of 440%, and disposable vapes witnessed a rise of 160%. In the United States, hybrid strain pre-rolls increased by 63%, disposable vape pens by 60%, and infused pre-rolls by 22%.

The white paper highlights potency as a crucial factor influencing consumer choices, as infused pre-rolls offer higher potency than standard pre-rolls. Additionally, the advancement of pre-roll machinery has enabled keeping prices affordable while maintaining high potency levels.

The white paper also discusses an intriguing trend concerning the price compression of cannabis products across various categories. In the United States, prices for beverages, concentrates, edibles, pre-rolls, and vape pens are experiencing a downward trend. Similarly, prices in all categories except pre-rolls are declining in Canada.

The paper suggests that if you are involved in the cannabis industry and concerned about decreasing profit margins, expanding into the pre-roll category can be a strategic move to sustain and enhance profitability.  While some have suggested pre-rolls are a way for dispensaries to get rid of lower quality cannabis flower, effectively pre-packaging it for the consumer, many have debated this point in the marijuana industry.

According to Custom Cones USA, 58.4% of companies surveyed confirmed their involvement in producing or selling infused pre-rolls. The white paper further elucidates a correlation between the declining prices of regular pre-rolls and the increasing prices of infused pre-rolls. Furthermore, the report highlights a significant surge in the popularity of multi-pack pre-rolls. Since 2021, there has been an estimated 400% growth in multi-packs containing at least two to five grams of cannabis.

While different generations of adults exhibit preferences for specific cannabis products, pre-rolls maintain a consistent appeal across all age groups. Baby boomers show a preference rate of 12.8% for pre-rolls, Generation X follows closely at 13.6%, millennials at 14.5%, and Generation Z at 14.4%.

Will Canadian Businesses Expand?

In the Canadian cannabis industry, pre-rolls are experiencing significant growth and momentum. Approximately 50% of cannabis companies in Canada are relatively young, being less than three years old. Comparatively, 18.9% fall within the four to five years old category, and 20.5% fall within the six to seven years old category. The white paper emphasizes the industry’s maturation, particularly in pre-roll businesses.

Nevertheless, projections and questions regarding future adjustments and changes within the industry exist. One aspect under scrutiny is whether Canadian businesses will expand into the United States. Additionally, there is speculation on how emerging cannabis markets in the United States can match the pre-roll production rates of businesses in more established markets.

In the quest for expansion, the white paper advises cannabis businesses to consider several factors. First and foremost, companies should assess their monthly pre-roll production capacity. Studying the packaging methods and machines employed by other brands in the industry is also important.

Additionally, companies should determine whether pre-rolls are weighed before packaging and be mindful of the average size of pre-rolls, typically measured in grams. These considerations can provide valuable insights for cannabis businesses expanding their operations.

According to the white paper’s analysis, pre-rolls are identified as a continuously growing trend in the cannabis industry. Based on the examined data, the paper projects that pre-rolls will surpass flower as the largest product category by 2030.

The convenience of pre-rolls as a consumption method, where one needs to add fire, along with the increasing popularity of infused pre-rolls and multi-packs, will drive the market forward. As the quality of pre-rolls continues to improve, it is foreseeable that pre-rolls will eventually surpass the flower category.

Conclusion

The white paper on “The State of the Pre-Roll Industry” provides valuable insights into the dynamic landscape of the cannabis market. It highlights the continued growth and potential of pre-rolls as a dominant product category within the industry. With compelling data and projections, the report showcases the rise of infused pre-rolls, multi-packs and the convenience they offer to consumers. Notably, pre-rolls are expected to surpass flower as the largest selling category by 2030, driven by convenience, increasing quality, and evolving consumer preferences.

Furthermore, the paper addresses important considerations for cannabis businesses, including production capacity, packaging methods, pre-roll weighing practices, and average size. By acknowledging these factors, companies can make informed decisions to capitalize on the expanding pre-roll market. This white paper is a valuable resource for industry professionals, providing insights and guidance in navigating the ever-changing cannabis landscape.

Source: https://cannabis.net/blog/news/pay-someone-else-to-roll-your-joint-you-bet-cannabis-preroll-sales-grow-faster-than-any-other-c

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News